Health Care & Life Sciences » Pharmaceuticals | Bliss GVS Pharma Ltd.

Bliss GVS Pharma Ltd. | Cash Flow

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Net Income before Extraordinaries
706
960
1,482
1,754
1,795
Depreciation, Depletion & Amortization
107
123
143
201
214
Other Funds
37
102
16
-
-
Funds from Operations
491
990
1,136
1,755
1,460
Changes in Working Capital
219
609
83
503
590
Net Operating Cash Flow
709
380
1,052
2,258
870
Capital Expenditures
574
396
133
1,037
282
Sale of Fixed Assets & Businesses
-
33
7
26
40
Purchase/Sale of Investments
-
-
1
548
601
Net Investing Cash Flow
574
404
588
2,344
197
Cash Dividends Paid - Total
49
86
62
-
74
Issuance/Reduction of Debt, Net
251
120
190
632
818
Net Financing Cash Flow
165
309
236
566
1,089
Net Change in Cash
300
333
229
301
46
Free Cash Flow
137
13
919
1,221
588
Net Assets from Acquisitions
-
-
-
-
250
Other Sources
-
-
18
-
88
Exchange Rate Effect
-
-
-
180
24
Other Uses
-
42
479
785
-

About Bliss GVS Pharma

View Profile
Address
102, Hyde Park
Mumbai Maharashtra 400072
India
Employees -
Website http://www.blissgvs.com
Updated 09/14/2018
Bliss GVS Pharma Ltd. engages in the development, manufacture, and marketing of pharmaceutical formulations. Its products include capsules; creams, gels, and ointment; dry powder for injection and oral suspension; effervescent tablets; eye and ear drops; injection; liquid preparations; lotions; lozenges; nasal solution; oral solids; parenterals; pessaries; sachets; soft gelatin capsules; suppositories; suspension; syrups; tablets; and topical preparations. The company was founded on December 11, 1984 and is headquartered in Mumbai, India.